Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.
about
Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Short-Term Adjuvant Therapy wi ...... In Vitro and In Vivo Evidence.
@en
type
label
Short-Term Adjuvant Therapy wi ...... In Vitro and In Vivo Evidence.
@en
prefLabel
Short-Term Adjuvant Therapy wi ...... In Vitro and In Vivo Evidence.
@en
P2093
P2860
P1476
Short-Term Adjuvant Therapy wi ...... In Vitro and In Vivo Evidence.
@en
P2093
Deepak Kaul
Dimple Trikha
Divya Kapoor
K K Parashar
Veena Dhawan
P2860
P2888
P304
P356
10.1007/S12265-015-9620-X
P407
P577
2015-04-01T00:00:00Z
P6179
1008184946